AGP Executive Report
Last update: 5 hours agoEbola Response: China is sending emergency medical teams and supplies to the DRC as suspected Ebola cases keep rising, while WHO urges countries to reconsider travel restrictions. Medicare & Medicaid Pressure: Boston Medical Center warns of losses ahead of looming Medicaid cuts, and Medicaid fraud enforcement remains in the spotlight as states and the federal government clash over how to fight scams. Drug Safety & Access: England’s ramipril recall highlights how packaging errors can expose patients to the wrong dose; separately, Medicare’s new GLP-1 coverage plan for obesity is set to start July 1, but the cost to taxpayers is still unclear. Clinical Research Moves: Rejuvenate Biomed completed Phase 2 recruitment for RJx-01 in COPD-induced sarcopenia, while Lynk Pharmaceuticals gained NMPA approval to start Phase 2 for LNK01004 ointment in vitiligo and chronic hand eczema. Imaging & Care Coordination: The NHS is rolling out a single patient record to reduce repeated history-taking, and the University of Cincinnati opened an MRI research center with GE HealthCare to speed trials and improve scan workflows. Healthcare Oversight: A major investigation flags “risky medicine” in Georgia after Tennessee regulators targeted chelation, and the Society of Interventional Radiology backs the ROOT Act to curb low-value imaging.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
